Our observation that intermediate monocytes (CD14+CD16+) with CD11c+ and HLA-DR+ expression correlation with the amount of macrophages from the lung cancer microenvironment may indicate role a of these cells in cancer immunity. This evidence concerns the gene FCGR3A and lung cancer.